vs
雅培（CLB）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是RE/MAX Holdings, Inc.的1.7倍（$121.8M vs $71.1M），雅培净利率更高（4.2% vs 2.0%，领先2.2%），雅培同比增速更快（-1.4% vs -1.8%），RE/MAX Holdings, Inc.自由现金流更多（$33.5M vs $517.0K），过去两年雅培的营收复合增速更高（-3.4% vs -4.7%）
雅培是一家总部位于美国伊利诺伊州阿伯特公园的跨国医疗保健企业，在全球医疗健康领域开展业务，主营诊断产品、营养健康产品、医疗器械，同时在美国境外销售医药产品，是全球知名的医疗健康提供商。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
CLB vs RMAX — 直观对比
营收规模更大
CLB
是对方的1.7倍
$71.1M
营收增速更快
CLB
高出0.4%
-1.8%
净利率更高
CLB
高出2.2%
2.0%
自由现金流更多
RMAX
多$33.0M
$517.0K
两年增速更快
CLB
近两年复合增速
-4.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $121.8M | $71.1M |
| 净利润 | $5.1M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | 1.5% | 13.1% |
| 净利率 | 4.2% | 2.0% |
| 营收同比 | -1.4% | -1.8% |
| 净利润同比 | — | -75.2% |
| 每股收益（稀释后） | $0.11 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLBRMAX
| Q1 26 | $121.8M | — | ||
| Q4 25 | $138.3M | $71.1M | ||
| Q3 25 | $134.5M | $73.2M | ||
| Q2 25 | $130.2M | $72.8M | ||
| Q1 25 | $123.6M | $74.5M | ||
| Q4 24 | $129.2M | $72.5M | ||
| Q3 24 | $134.4M | $78.5M | ||
| Q2 24 | $130.6M | $78.5M |
净利润CLBRMAX
| Q1 26 | $5.1M | — | ||
| Q4 25 | $4.9M | $1.4M | ||
| Q3 25 | $14.2M | $4.0M | ||
| Q2 25 | $10.6M | $4.7M | ||
| Q1 25 | $-154.0K | $-2.0M | ||
| Q4 24 | $7.4M | $5.8M | ||
| Q3 24 | $11.7M | $966.0K | ||
| Q2 24 | $9.0M | $3.7M |
毛利率CLBRMAX
| Q1 26 | — | — | ||
| Q4 25 | 20.8% | — | ||
| Q3 25 | 22.0% | — | ||
| Q2 25 | 20.3% | — | ||
| Q1 25 | 19.5% | — | ||
| Q4 24 | 17.8% | — | ||
| Q3 24 | 20.5% | — | ||
| Q2 24 | 21.2% | — |
营业利润率CLBRMAX
| Q1 26 | 1.5% | — | ||
| Q4 25 | 11.5% | 13.1% | ||
| Q3 25 | 15.6% | 25.0% | ||
| Q2 25 | 11.7% | 19.3% | ||
| Q1 25 | 3.6% | 7.2% | ||
| Q4 24 | 11.0% | 5.9% | ||
| Q3 24 | 14.7% | 19.4% | ||
| Q2 24 | 12.3% | 20.6% |
净利率CLBRMAX
| Q1 26 | 4.2% | — | ||
| Q4 25 | 3.6% | 2.0% | ||
| Q3 25 | 10.6% | 5.4% | ||
| Q2 25 | 8.2% | 6.4% | ||
| Q1 25 | -0.1% | -2.6% | ||
| Q4 24 | 5.7% | 8.0% | ||
| Q3 24 | 8.7% | 1.2% | ||
| Q2 24 | 6.9% | 4.7% |
每股收益（稀释后）CLBRMAX
| Q1 26 | $0.11 | — | ||
| Q4 25 | $0.11 | — | ||
| Q3 25 | $0.30 | — | ||
| Q2 25 | $0.22 | — | ||
| Q1 25 | $0.00 | — | ||
| Q4 24 | $0.15 | — | ||
| Q3 24 | $0.25 | — | ||
| Q2 24 | $0.19 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.8M | $118.7M |
| 总债务越低越好 | — | $432.2M |
| 股东权益账面价值 | $275.1M | $452.4M |
| 总资产 | $587.7M | $582.5M |
| 负债/权益比越低杠杆越低 | — | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资CLBRMAX
| Q1 26 | $22.8M | — | ||
| Q4 25 | $22.7M | $118.7M | ||
| Q3 25 | $25.6M | $107.5M | ||
| Q2 25 | $31.2M | $94.3M | ||
| Q1 25 | $22.1M | $89.1M | ||
| Q4 24 | $19.2M | $96.6M | ||
| Q3 24 | $21.5M | $83.8M | ||
| Q2 24 | $17.7M | $66.1M |
总债务CLBRMAX
| Q1 26 | — | — | ||
| Q4 25 | $110.3M | $432.2M | ||
| Q3 25 | $114.1M | $433.3M | ||
| Q2 25 | $124.6M | $434.4M | ||
| Q1 25 | $124.4M | $435.3M | ||
| Q4 24 | $126.1M | $436.2M | ||
| Q3 24 | $139.9M | $437.2M | ||
| Q2 24 | $147.6M | $438.1M |
股东权益CLBRMAX
| Q1 26 | $275.1M | — | ||
| Q4 25 | $266.0M | $452.4M | ||
| Q3 25 | $271.3M | $448.1M | ||
| Q2 25 | $261.3M | $442.4M | ||
| Q1 25 | $253.4M | $433.5M | ||
| Q4 24 | $246.6M | $429.5M | ||
| Q3 24 | $250.7M | $423.1M | ||
| Q2 24 | $240.3M | $418.4M |
总资产CLBRMAX
| Q1 26 | $587.7M | — | ||
| Q4 25 | $584.0M | $582.5M | ||
| Q3 25 | $591.4M | $582.2M | ||
| Q2 25 | $602.1M | $574.8M | ||
| Q1 25 | $591.5M | $571.4M | ||
| Q4 24 | $585.1M | $581.6M | ||
| Q3 24 | $600.5M | $578.6M | ||
| Q2 24 | $597.8M | $571.4M |
负债/权益比CLBRMAX
| Q1 26 | — | — | ||
| Q4 25 | 0.41× | 0.96× | ||
| Q3 25 | 0.42× | 0.97× | ||
| Q2 25 | 0.48× | 0.98× | ||
| Q1 25 | 0.49× | 1.00× | ||
| Q4 24 | 0.51× | 1.02× | ||
| Q3 24 | 0.56× | 1.03× | ||
| Q2 24 | 0.61× | 1.05× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.0M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | $517.0K | $33.5M |
| 自由现金流率自由现金流/营收 | 0.4% | 47.1% |
| 资本支出强度资本支出/营收 | — | 10.4% |
| 现金转化率经营现金流/净利润 | 0.77× | 28.39× |
| 过去12个月自由现金流最近4个季度 | $22.5M | $56.8M |
8季度趋势，按日历期对齐
经营现金流CLBRMAX
| Q1 26 | $4.0M | — | ||
| Q4 25 | $7.9M | $40.9M | ||
| Q3 25 | $8.5M | $17.7M | ||
| Q2 25 | $13.9M | $4.6M | ||
| Q1 25 | $6.7M | $5.7M | ||
| Q4 24 | $20.6M | $59.7M | ||
| Q3 24 | $13.1M | $17.6M | ||
| Q2 24 | $17.1M | $15.9M |
自由现金流CLBRMAX
| Q1 26 | $517.0K | — | ||
| Q4 25 | $5.0M | $33.5M | ||
| Q3 25 | $6.5M | $16.4M | ||
| Q2 25 | $10.4M | $2.9M | ||
| Q1 25 | $3.9M | $4.0M | ||
| Q4 24 | $17.4M | $53.0M | ||
| Q3 24 | $10.4M | $16.3M | ||
| Q2 24 | $14.3M | $14.0M |
自由现金流率CLBRMAX
| Q1 26 | 0.4% | — | ||
| Q4 25 | 3.6% | 47.1% | ||
| Q3 25 | 4.8% | 22.4% | ||
| Q2 25 | 8.0% | 4.0% | ||
| Q1 25 | 3.1% | 5.3% | ||
| Q4 24 | 13.4% | 73.2% | ||
| Q3 24 | 7.7% | 20.8% | ||
| Q2 24 | 10.9% | 17.8% |
资本支出强度CLBRMAX
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 10.4% | ||
| Q3 25 | 1.5% | 1.8% | ||
| Q2 25 | 2.7% | 2.2% | ||
| Q1 25 | 2.3% | 2.3% | ||
| Q4 24 | 2.5% | 9.1% | ||
| Q3 24 | 2.0% | 1.7% | ||
| Q2 24 | 2.2% | 2.4% |
现金转化率CLBRMAX
| Q1 26 | 0.77× | — | ||
| Q4 25 | 1.61× | 28.39× | ||
| Q3 25 | 0.60× | 4.45× | ||
| Q2 25 | 1.31× | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.78× | 10.28× | ||
| Q3 24 | 1.12× | 18.22× | ||
| Q2 24 | 1.90× | 4.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLB
暂无分部数据
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
